Lobbying organisation

Edesa Biotech Research, Inc.

9 meetings with public office holders, Oct 17, 2025 to Apr 29, 2026.

17 meetings on record since 2020, their first on record.

Meetings over time

Oct 20253 meetingsManuela Tomic, Sandenga Yeba, Shahad Khalladi
Oct 2025: 3 meetings, with Manuela Tomic, Sandenga Yeba, Shahad Khalladi
Nov 20252 meetingsPamela Aung-Thin, Hiba Kandalaft
Nov 2025: 2 meetings, with Pamela Aung-Thin, Hiba Kandalaft
Dec 20250 meetings
Dec 2025: 0 meetings
Jan 20260 meetings
Jan 2026: 0 meetings
Feb 20261 meetingManuela Tomic
Feb 2026: 1 meeting, with Manuela Tomic
Mar 20262 meetingsManuela Tomic, Justine Frame
Mar 2026: 2 meetings, with Manuela Tomic, Justine Frame
Apr 20261 meetingManuela Tomic
Apr 2026: 1 meeting, with Manuela Tomic

Oct 2025peak 3 in a monthApr 2026

Hover or focus a month to see who was met.

What they lobby about

The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.

Who they met

Not in Arena's member list6 met · 11 meetings

Manuela Tomic
Pamela Aung-Thin
Hiba Kandalaft
Justine Frame
Sandenga Yeba
Shahad Khalladi

Innovation, Science and Economic Development Canada (ISED) (5) · Health Canada (HC) (5) · National Defence (DND) (1)

In their own words

Seeking funding to allow for increased research and development and other expenditures into two clinical-stage antibodies to treat acute respiratory distress syndrome (the primary cause of death from COVID-19) from the Industrial Research Assistance Program and the Strategic Innovation Fund.
Discussing biomanufacturing initiatives in Canada globally as it relates to federal government policy, including with respect to defence uses.
To update and discuss current Strategic Innovation Fund (SIF) funding as well as biomanufacturing initiatives in Canada and globally.

Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.